FDA Inspection 1166620 — Southern Blood Services, Inc

Southern Blood Services, Inc — FEI 3007179827

The FDA completed an inspection of Southern Blood Services, Inc on April 6, 2022 in Tuscaloosa, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 6, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tuscaloosa, AL (United States)